Whole exome sequencing (WES) of circulating tumor DNA (ctDNA) in patients with neuroendocrine prostate cancer (NEPC) informs tumor heterogeneity.

Himisha Beltran(Dana-Farber Cancer Institute), Francesca Demichelis(University of Trento), Jenny Xiang(Cornell University), Matteo Benelli(Azienda Ospedaliero-Universitaria Careggi), Nicola Casiraghi(University of Trento), Alessandro Romanel(University of Trento), Michael Sigouros(Cornell University)
Journal of Clinical Oncology
May 20, 2017
Cited by 15


Related Papers